The HPV vaccine (Gardasil 9) cost in Singapore sits at roughly S$250 a dose and S$700 to S$720 for the full three-dose course at private clinics as of October 2026. That is the sticker price almost everyone pays, because Gardasil 9 is the broadest HPV vaccine but the one the government does not yet subsidise or let you claim through MediSave. That changes on 1 January 2027, when MOH adds it to the national schedules for females aged 9 to 26. The cheaper, fully-subsidised route uses Cervarix, where a CHAS Blue or Orange cardholder can pay as little as S$23 a dose. This guide breaks down both vaccines, who actually pays full price, and how to spend the least while still getting protected.
Gardasil 9 is sold per dose at most private GP and screening clinics, and the figure has held steady at around S$250 NETT a dose through October 2026. The three-dose course therefore lands between S$700 and S$720 at the providers we checked, with the spread coming down to whether a clinic bundles the doctor's consultation into the package or charges it separately on the first visit.
Raffles Health, for example, lists a three-dose Gardasil 9 package at S$720 that already folds in the practice cost and first-visit consultation, valid for 12 months. Singapore Women's Clinic and several screening clinics quote S$250 a dose with the full course landing near S$700. A few outreach providers price each dose higher at around S$294 but then knock the bundle down, so the per-dose headline is not always the cheapest path.
The number that catches people out is consultation. A single S$250 dose at a clinic that charges a separate consult can quietly become S$280 to S$320 on your first visit. Ask for the all-in price before you book, the same way you would compare clinic fees for anything else.
| Vaccine | Per dose | Full course | MediSave | Subsidy |
|---|---|---|---|---|
| Gardasil 9 (9-valent) | From ~S$250 | ~S$700-S$720 (3 doses) | No (yes for females 9 to 26 from 1 Jan 2027) | None until 1 Jan 2027 |
| Cervarix (2-valent), CHAS Blue/Orange | Up to S$23 | Up to ~S$69 (3 doses) | Yes | CHAS + NAIS |
| Cervarix, CHAS Green / non-CHAS | Up to S$45 | Up to ~S$135 (3 doses) | Yes | NAIS |
| Cervarix, private (no subsidy) | ~S$96 | ~S$288 (3 doses) | Yes | None |
| School programme (Sec 1 & 2 girls) | S$0 | S$0 | n/a | Fully funded |
Update, 14 October 2026: MOH said on 2 October 2026 that from 1 January 2027 Gardasil 9 (HPV9) joins the national immunisation schedules for Singaporean and PR females aged 9 to 26. Citizen children will get it fully subsidised at CHAS GP clinics and polyclinics, citizen adults means-tested subsidies of up to 75%, PRs subsidies at polyclinics, and MediSave can pay up to the S$700 or S$1,000 Chronic and Preventive Care limits. Men are not included. Until then, the rules below apply. Singapore's subsidy framework backs the vaccine the health authorities deem most cost-effective for cervical cancer prevention, and that vaccine is Cervarix, not Gardasil 9. Under the National Adult Immunisation Schedule, Cervarix is both subsidised and MediSave-claimable for female Singapore Citizens and Permanent Residents from age 9 up to before their 27th birthday. Gardasil 9 sits outside that schedule.
The practical effect is blunt. If you choose Gardasil 9, you bear the full course cost yourself, with no CHAS discount and no MediSave drawdown. People assume the pricier vaccine must be the one MediSave covers because it offers wider protection against nine HPV types instead of two. It is the reverse. The broader vaccine is the one you pay for in cash.
This is the single most important money decision in the whole topic, and it mirrors how CHAS subsidies work elsewhere in primary care: the subsidised option is fixed, and stepping up to a premium product means stepping outside the subsidy.
Cervarix protects against HPV types 16 and 18, which drive about 70 percent of cervical cancer cases. Gardasil 9 covers those two plus types 31, 33, 45, 52 and 58 (more cancer-linked strains) and types 6 and 11, which cause most genital warts. So the cheaper route covers the lion's share of cervical cancer risk, while the premium route adds breadth and wart protection.
There is also an eligibility gap. Cervarix is approved for females aged 9 to 25 only. Gardasil 9 is approved for both females and males aged 9 to 45. If you are male, over 26, or want wart coverage, Gardasil 9 is effectively your only option, and the subsidy question is moot because you would not qualify for the Cervarix subsidy anyway.
Dosing is age-based, and it has a real effect on total cost. People aged 9 to 14 need only two doses, given roughly six months apart. People aged 15 and above need three doses, with the second about two months after the first and the third about four months after the second.
On Gardasil 9 that means a 14-year-old paying privately spends around S$500 for two doses, while a 20-year-old spends around S$700 to S$720 for three. Starting earlier saves a full dose, so a family planning ahead can budget around vaccinating before the 15th birthday. If you want to model the saving against other health and insurance outlays, our personal budget calculator makes the trade-offs concrete.
Girls in Secondary 1 and Secondary 2 are offered HPV vaccination free under the national school-based programme run by the Health Promotion Board, using Cervarix (HPV2) in 2026; Gardasil 9 replaces it from 1 January 2027. If your daughter is in this group, there is no reason to pay a clinic. Students who miss it can usually arrange a deferred dose through the programme.
For adult women, the cheapest legitimate path is Cervarix at a CHAS GP clinic or polyclinic. At a CHAS GP clinic, a Singapore Citizen aged 18 to 26 with a CHAS Blue or Orange card pays at most S$23 a dose, and a CHAS Green or non-CHAS holder up to S$45; polyclinics means-test the subsidy instead, and citizen girls aged 9 to 17 pay nothing at either. MediSave can cover the remaining out-of-pocket cost. The Temasek Foundation programme that fully funded Cervarix for CHAS Blue and Orange cardholders ended on 30 June 2026.
If you are weighing vaccination against your broader health cover, it pays to understand where prevention sits relative to your hospital insurance and what MediShield Life does and does not pay for.
For Gardasil 9, private GP clinics, screening clinics and groups like Raffles Health all offer it, and prices cluster tightly enough that location and consultation policy matter more than the vaccine markup itself. For subsidised Cervarix, you need a polyclinic or a CHAS GP clinic, since the subsidy does not follow you to a private specialist.
A few habits keep the bill honest. Confirm whether the quote is per dose or full course and whether consultation is included. Ask if your CHAS card or MediSave applies before, not after, the jab. And if you are eligible for the school programme or the Cervarix subsidy, take it rather than defaulting to the priciest option.
Gardasil 9 costs about S$250 a dose at private clinics, and roughly S$700 to S$720 for the full three-dose course, as of October 2026. Two-dose courses for ages 9 to 14 run closer to S$500. Prices vary by clinic and whether consultation is bundled.
Not in 2026. Gardasil 9 is not yet on the National Adult Immunisation Schedule, so it cannot be claimed through MediSave and gets no CHAS subsidy. From 1 January 2027 it joins the national schedules for females aged 9 to 26, with subsidies at polyclinics and CHAS GP clinics and MediSave up to the Chronic and Preventive Care limits. Only Cervarix is subsidised and MediSave-claimable, for female Singapore Citizens and PRs aged 9 to before 27.
The cheapest route is subsidised Cervarix at a polyclinic or CHAS GP clinic, where a CHAS Blue or Orange cardholder pays up to S$23 a dose. Secondary 1 and 2 girls get Cervarix free through the school programme in 2026, and Gardasil 9 from 2027, which is the best deal of all.
Yes. Gardasil 9 is approved for males and females aged 9 to 45, so men can get it at private clinics for the same roughly S$250 a dose. There is no subsidy or MediSave claim for men, since the national HPV subsidy applies only to eligible females.
This is general financial information for Singapore, not personal financial advice. Figures change, so verify current rates against the official sources above before acting. See our full disclaimer.
Junxiong-WFG Organisation is an authorised representative of AIA Financial Advisers Private Limited (Reg. No. 201715016G).